Artificial Intelligence (AI) has emerged as a transformative force in healthcare, offering significant potential to address workforce challenges and improve patient outcomes. This perspective article presents a framework for responsible AI innovation, emphasising ethical governance, responsible leadership and a commitment to human-centred AI. It provides guidance for healthcare organisations to position AI as a strategic enabler, augmenting the health and care workforce and fostering sustainable, patient-centred advancements in healthcare.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/hpm.3927 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Electrochemical biosensing in oncology: a review advancements and prospects for cancer diagnosis.
Cancer Biol Ther
December 2025
Department of Surgery, Hamad Medical Corporation, Doha, Qatar.
Early and precise diagnosis of cancer is pivotal for effective therapeutic intervention. Traditional diagnostic methods, despite their reliability, often face limitations such as invasiveness, high costs, labor-intensive procedures, extended processing times, and reduced sensitivity for early-stage detection. Electrochemical biosensing is a revolutionary method that provides rapid, cost-effective, and highly sensitive detection of cancer biomarkers.
View Article and Find Full Text PDFLarge Language Model-Based Critical Care Big Data Deployment and Extraction: Descriptive Analysis.
JMIR Med Inform
March 2025
Department of Critical Care Medicine, Beijing Tiantan Hospital, Capital Medical University, No.119 Nansihuanxi Road, Fengtai District, Beijing, 100070, China, 86 17611757717.
Background: Publicly accessible critical care-related databases contain enormous clinical data, but their utilization often requires advanced programming skills. The growing complexity of large databases and unstructured data presents challenges for clinicians who need programming or data analysis expertise to utilize these systems directly.
Objective: This study aims to simplify critical care-related database deployment and extraction via large language models.
Development of a tertiary lymphoid structure-based prognostic model for breast cancer: integrating single-cell sequencing and machine learning to enhance patient outcomes.
Front Immunol
March 2025
Research Laboratory Center, Guizhou Provincial People's Hospital, Guiyang, Guizhou, China.
Background: Breast cancer, a highly prevalent global cancer, poses significant challenges, especially in advanced stages. Prognostic models are crucial to enhance patient outcomes. Tertiary lymphoid structures (TLS) within the tumor microenvironment have been associated with better prognostic outcomes.
View Article and Find Full Text PDFKAN-EEG: towards replacing backbone-MLP for an effective seizure detection system.
R Soc Open Sci
March 2025
School of Biomedical Engineering, Faculty of Engineering, The University of Sydney, Sydney, NSW 2006, Australia.
The landscape of artificial intelligence (AI) research is witnessing a transformative shift with the emergence of the Kolmogorov-Arnold network (KAN), presenting a novel architectural paradigm aimed to redefine the structural foundations of AI models, which are based on multilayer perceptron (MLP). Through rigorous experimentation and evaluation, we introduce the KAN-electroencephalogram (EEG) model, a tailored design for efficient seizure detection. Our proposed network is tested and successfully generalized on three different datasets, one from the USA, one from Europe, and one from Oceania, recorded with different front-end hardware.
View Article and Find Full Text PDFArtificial Intelligence Screening Tool for Obstructive Sleep Apnoea: A Study Based on Outpatients at a Sleep Medical Centre.
Nat Sci Sleep
March 2025
Department of Otorhinolaryngology, the Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430014, People's Republic of China.
Purpose: Due to the lack of clear screening guidelines for different populations, identify strategies for obstructive sleep apnea (OSA) in the outpatient population are unclear, a large number of potential OSA outpatients have not been identified in time. The purpose of our study was to evaluate the applicability and accuracy of artificial intelligence sleep screening in outpatients and to provide a reference for OSA screening in different populations.
Methods: A type IV wearable artificial intelligence sleep monitoring (AISM) device was used to screen adults in the sleep clinic of the Sleep Medical Center for OSA screening, and the general demographic data of the patients were collected.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!